Ertugliflozin

Active Ingredient: Ertugliflozin
Form: Oral tablet
Brand Name: Steglatro
Generic Name: Ertoxa
Generic Manufacturer: Ziska Pharmaceuticals

Indications:
Steglatro is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is not recommended for patients with type 1 diabetes or diabetic ketoacidosis.

Dosage and Administration:
The starting dose is 5 mg orally once daily. The dose may be increased to a maximum of 15 mg once daily based on tolerance. In patients with renal impairment, dosage should be adjusted based on estimated glomerular filtration rate (eGFR).

Common Side Effects:
Cough, nasal congestion, sore throat, mouth ulcers, diarrhea, nausea, abdominal pain, constipation, weight loss, dizziness, back pain, joint and muscle pain, weakness, and tremor.

Storage:
Store in a dry place below 30°C, away from light and out of reach of children.

Frequently Asked Questions

Q: What is the relationship between Steglatro and Ertugliflozin?
A: Steglatro is the brand name registered by the original manufacturer. Ertugliflozin is its active ingredient.

Q: Is the Steglatro sold by Mediva Rx the original brand-name drug?
A: No. Mediva Rx provides a high-quality generic version manufactured by one of Bangladesh’s top 10 pharmaceutical companies. It contains the same active ingredient and therapeutic effect as the original, and is tested and approved by the Directorate General of Drug Administration (DGDA).

Q: Is the manufacturer of this generic version reliable?
A: Yes. Ziska Pharmaceuticals is one of Bangladesh’s leading pharmaceutical companies, with its own R&D, manufacturing, and quality control labs. It is certified to meet international pharmaceutical manufacturing standards. You can purchase with confidence.

Disclaimer:
This information is for reference only. Please consult your doctor and refer to the official medication guide and latest clinical research before making treatment decisions.

Drug Instructions (Package Insert):
Download Link